SCHEMBL4374933

SCHEMBL4374933

CCC(N)CCCC(N)c1ccnc2cc(Cl)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.46
SOS2 Q07890 1/20 0.46
CHRM2 P08172 2/20 0.43
CHRM4 P08173 2/20 0.43
CHRM5 P08912 2/20 0.43
ADRA2A P08913 2/20 0.43
CHRM1 P11229 2/20 0.43
ADRA2B P18089 2/20 0.43
ADRA2C P18825 2/20 0.43
CHRM3 P20309 2/20 0.43
KCNH2 Q12809 2/20 0.43
TMEM97 Q5BJF2 2/20 0.43
SIGMAR1 Q99720 2/20 0.43
ACE2 Q9BYF1 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PRNP P04156 1/20 0.43
APP P05067 1/20 0.43
NQO2 P16083 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27466150 0.85 NR4A2 (0.49) NR4A2SOS2CCR1FERMT2CYP1A2
SCHEMBL902310 0.84 FERMT2 (0.56) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL4367045 0.83 FERMT2 (0.56) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL4365534 0.82 FERMT2 (0.55) NR4A2SOS2TDP1PRNPCCR1
SCHEMBL4374938 0.81 CCR1 (0.49) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL6661654 0.81 NR4A2 (0.50) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL29625389 0.81 NR4A2 (0.50) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL5275609 0.78 NR4A2 (0.56) NR4A2SOS2TDP1PRNPCCR1
SCHEMBL8539820 0.78 NR4A2 (0.47) NR4A2SOS2CHRM2CHRM4CHRM5
SCHEMBL4377782 0.75 CHRM2 (0.52) NR4A2CHRM2CHRM4CHRM5ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009148659-A2 ANTIMALARIAL QUINOLINES AND METHODS OF USE THEREOF GEORGETOWN UNIVERSITY (US) 2009-12-10 WO disclosed